Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy variable 4-61 (IGHV4-61) is a variable (V) gene segment within the immunoglobulin heavy chain (IGH) locus on human chromosome 14q32.33[1][6]. It encodes the V region of the heavy chain in antibodies, which forms part of the antigen binding site together with the light chain variable region[5][6][3]. As a variable gene segment, IGHV4-61 undergoes somatic recombination with diversity (D) and joining (J) gene segments during B-cell development, enabling the immune system to generate a vast diversity of antibodies for recognition of pathogens[1][2][5]. IGHV4-61 is not itself a druggable therapeutic target (such as a receptor or enzyme), but allelic variation in IGHV4-61, such as the IGHV4-61*02 allele, has been associated with increased risk of specific autoimmune conditions, notably rheumatic heart disease[2]. IGHV4-61 is significant as a component of the antibody repertoire and as a potential biomarker for disease risk, but it is not a receptor or traditional drug target in therapeutic development[6][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy variable 4-61 (IGHV4-61).